This module equips students to work professionally and reflectively in the translation market dealing with medical and pharmaceutical texts. The module...

This module equips students to work professionally and reflectively in the translation market dealing with medical and pharmaceutical texts. The module provides students with the relevant competences to translate medical text types. Students will be introduced to medical translation through lectures and language-specific, interactive seminars. After introductory sessions on the characteristics of medical translation, students will work in language-specific groups, where they will translate a wide range of specialised texts belonging to medical/pharmaceutical domains (to include patient information leaflets, clinical trials, case reports, healthcare documents, informed consent forms, pharmaceutical reports, etc.)

Students eligible for this module must select preferences for their preferred language combination prior to enrolment and normally before the 31st of July. SELCS/CMII will send preference selection instructions to eligible offer holders. We cannot guarantee that any given language combination will run unless this deadline is strictly adhered to. Students must have excellent competence in one of the language pairs listed below. Students are expected to translate into their native language.

From English into Arabic, Chinese, French, German, Greek, Italian, Japanese, Korean, Norwegian, Polish, Portuguese, Romanian, Russian, Spanish and Turkish.

From French, German or Spanish into English

CANCER BIOLOGY|CANCER TREATMENT|HALLMARKS OF CANCER

This module helps you to understand the mechanisms of different cancer therapies, and how these relate to the underlying cancer biology. You will begin the...

This module helps you to understand the mechanisms of different cancer therapies, and how these relate to the underlying cancer biology. You will begin the module with workshops to develop your understanding of evidence based medicine and your skills for critical evaluation of clinical trials. You will then learn about the mechanisms and application of standard therapies (such as chemotherapy, radiotherapy and surgery), and of targeted therapies representing personalised cancer medicine, and the evidence supporting these. You will review the hallmarks of cancer, as defined by Hanahan and Weinberg, and will investigate how different therapies have been designed to target these hallmark features of cancer cells.

 This module will consist of a mixture of lectures, interactive tutorials, discussion workshops and self-directed learning. You will also attend research-in-progress seminars from PhD students and postdoctoral researchers. Topics in this module include:

  Evidence Based Medicine
 
  Non-Targeted Cancer Therapies
 
  Therapies Targeting:–  Sustained Proliferative Signalling
 
  Therapies Targeting:–  Evasion of Growth Suppressors
 
  Therapies Targeting:–  Resistance to Cell Death
 
  Therapies Targeting:–  Defective DNA Repair
 
  Therapies Targeting:–  the Deregulation of Cellular Energetics
 
  Therapies Targeting:–  the Induction of Angiogenesis
 
  Therapies Targeting:–  the Enabling of Replicative Immortality
 
  Therapies Targeting:–  the Activation of Invasion and Metastasis